# Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer

> **NCT00087256** · PHASE3 · TERMINATED · sponsor: **NSABP Foundation Inc** · enrollment: 18 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Celecoxib
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00087256
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-07
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** For scientific, logistic, and administrative reasons.
- **Last updated:** 2013-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00087256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00087256, "Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00087256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*